9,602 Hinge Health Inc. $HNGE Shares Sold by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky cut its holdings in shares of Hinge Health Inc. (NYSE:HNGE – Free Report) by 34.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,591 shares of the company’s stock after selling 9,602 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Hinge Health were worth $1,808,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. HighTower Advisors LLC purchased a new position in shares of Hinge Health during the third quarter valued at about $241,000. Alberta Investment Management Corp purchased a new stake in Hinge Health during the third quarter valued at approximately $18,563,000. Virtus Advisers LLC raised its holdings in Hinge Health by 20.0% during the 3rd quarter. Virtus Advisers LLC now owns 9,472 shares of the company’s stock valued at $921,000 after buying an additional 1,578 shares during the period. Allworth Financial LP lifted its holdings in shares of Hinge Health by 402.3% in the 3rd quarter. Allworth Financial LP now owns 437 shares of the company’s stock worth $42,000 after acquiring an additional 350 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in shares of Hinge Health by 107.3% during the third quarter. Russell Investments Group Ltd. now owns 292,610 shares of the company’s stock valued at $28,044,000 after buying an additional 151,460 shares during the period.

Insider Buying and Selling

In related news, CFO James Budge sold 35,907 shares of Hinge Health stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $121.62, for a total transaction of $4,367,009.34. Following the completion of the transaction, the chief financial officer directly owned 256,207 shares in the company, valued at approximately $31,159,895.34. This trade represents a 12.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Perez sold 4,100 shares of the company’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $100.20, for a total value of $410,820.00. Following the completion of the sale, the chief executive officer owned 4,100 shares in the company, valued at approximately $410,820. This represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,226,288 shares of company stock valued at $121,470,244 over the last quarter. 18.92% of the stock is currently owned by company insiders.

Hinge Health Stock Down 5.7%

Hinge Health stock opened at $108.00 on Friday. Hinge Health Inc. has a 52 week low of $30.08 and a 52 week high of $126.40. The stock has a 50-day moving average price of $105.68 and a 200 day moving average price of $72.38. The company has a market capitalization of $8.78 billion, a price-to-earnings ratio of 62.24, a price-to-earnings-growth ratio of 1.61 and a beta of 1.19.

Hinge Health (NYSE:HNGE – Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The company reported $0.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.44. The company had revenue of $234.97 million during the quarter. Hinge Health had a net margin of 21.02% and a return on equity of 66.96%. The business’s quarterly revenue was up 52.4% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.02) earnings per share. Research analysts anticipate that Hinge Health Inc. will post 1.56 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on HNGE shares. Evercore reissued an “outperform” rating and set a $105.00 target price on shares of Hinge Health in a research note on Wednesday, August 5th. Wells Fargo & Company boosted their price target on Hinge Health from $103.00 to $132.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 3rd. Needham & Company LLC raised their price target on shares of Hinge Health from $115.00 to $135.00 and gave the company a “buy” rating in a report on Tuesday, November 3rd. Wall Street Zen raised Hinge Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Finally, Barclays raised their price objective on Hinge Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a research report on Monday, October 12th. Two analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $118.93.

View Our Latest Report on HNGE

Hinge Health Profile

(Free Report)

Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company’s offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.

Read More

Institutional Ownership by Quarter for Hinge Health (NYSE:HNGE)

Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.